Studies aimed to identify new therapeutic agents and elucidate the possible mechanism(s) of resistance to anti-HER2 treatments were performed using LIM1215 and SW48 human colon cancer cell lines and the corresponding HER2-amplified derivatives and different xenograft models [91]. The gene discussed is ERBB2; the disease is malignant colon neoplasm.